Company intelligence / Profile preview
JES Kasih Nusantara Sejahtera
Jakarta Pusat, DKI Jakarta, Indonesia
- Ownership
- Private
- Development stage
- Other
01
Overview
PT JES Kasih Nusantara Sejahtera focuses on innovative immunotherapy, especially for autoimmune diseases, diabetes, lupus, and arrhythmia, reportedly under the direction or partnership with Dr. Terawan[2][7]. No public clinical trial or results dataset is available.
- Therapeutic areas
- ImmunologyEndocrinologyCardiovascular
- Modalities
- Immunotherapy
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on JES Kasih Nusantara Sejahtera.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on JES Kasih Nusantara Sejahtera.